carvedilol has been researched along with Endomyocardial Fibrosis in 2 studies
Endomyocardial Fibrosis: A condition characterized by the thickening of the ventricular ENDOCARDIUM and subendocardium (MYOCARDIUM), seen mostly in children and young adults in the TROPICAL CLIMATE. The fibrous tissue extends from the apex toward and often involves the HEART VALVES causing restrictive blood flow into the respective ventricles (CARDIOMYOPATHY, RESTRICTIVE).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The cardioprotective properties of carvedilol (a vasodilating beta-adrenoceptor blocking agent) were studied in a rat model of dilated cardiomyopathy induced by autoimmune myocarditis." | 3.70 | Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy. ( Aizawa, Y; Fuse, K; Hanawa, H; Hasegawa, G; Higuchi, H; Hirono, S; Ito, M; Kato, K; Kodama, M; Naito, M; Nakazawa, M; Ohta, Y; Tanabe, N; Watanabe, K, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, YJ | 1 |
| Xiang, MX | 1 |
| San, J | 1 |
| Cheng, G | 1 |
| Wang, SS | 1 |
| Watanabe, K | 1 |
| Ohta, Y | 1 |
| Nakazawa, M | 1 |
| Higuchi, H | 1 |
| Hasegawa, G | 1 |
| Naito, M | 1 |
| Fuse, K | 1 |
| Ito, M | 1 |
| Hirono, S | 1 |
| Tanabe, N | 1 |
| Hanawa, H | 1 |
| Kato, K | 1 |
| Kodama, M | 1 |
| Aizawa, Y | 1 |
2 other studies available for carvedilol and Endomyocardial Fibrosis
| Article | Year |
|---|---|
Effect of matrine and carvedilol on collagen and MMPs activity of hypertrophy myocardium induced by pressure overload.
Topics: Alkaloids; Animals; Carbazoles; Cardiomegaly; Carvedilol; Cells, Cultured; Collagen; Endomyocardial | 2006 |
Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy.
Topics: Animals; Body Weight; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Disease Progression; Endomyoc | 2000 |